9-104928254-G-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The ENST00000435915.1(ENSG00000226334):​n.358+344G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.752 in 152,310 control chromosomes in the GnomAD database, including 43,358 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.75 ( 43305 hom., cov: 33)
Exomes 𝑓: 0.71 ( 53 hom. )

Consequence

ENSG00000226334
ENST00000435915.1 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.426

Publications

21 publications found
Variant links:
Genes affected
ABCA1 (HGNC:29): (ATP binding cassette subfamily A member 1) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intracellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the ABC1 subfamily. Members of the ABC1 subfamily comprise the only major ABC subfamily found exclusively in multicellular eukaryotes. With cholesterol as its substrate, this protein functions as a cholesteral efflux pump in the cellular lipid removal pathway. Mutations in both alleles of this gene cause Tangier disease and familial high-density lipoprotein (HDL) deficiency. [provided by RefSeq, Sep 2019]
ABCA1 Gene-Disease associations (from GenCC):
  • hypoalphalipoproteinemia, primary, 1
    Inheritance: AD Classification: DEFINITIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • Tangier disease
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • apolipoprotein A-I deficiency
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BP6
Variant 9-104928254-G-C is Benign according to our data. Variant chr9-104928254-G-C is described in ClinVar as Benign. ClinVar VariationId is 369619.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.826 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000435915.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
LOC105376196
NR_188620.1
n.1122+344G>C
intron
N/A
ABCA1
NM_005502.4
MANE Select
c.-412C>G
upstream_gene
N/ANP_005493.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ENSG00000226334
ENST00000435915.1
TSL:3
n.358+344G>C
intron
N/A
ENSG00000226334
ENST00000820514.1
n.1164+344G>C
intron
N/A
ABCA1
ENST00000374736.8
TSL:1 MANE Select
c.-412C>G
upstream_gene
N/AENSP00000363868.3

Frequencies

GnomAD3 genomes
AF:
0.752
AC:
114251
AN:
151986
Hom.:
43268
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.833
Gnomad AMI
AF:
0.701
Gnomad AMR
AF:
0.764
Gnomad ASJ
AF:
0.817
Gnomad EAS
AF:
0.798
Gnomad SAS
AF:
0.802
Gnomad FIN
AF:
0.738
Gnomad MID
AF:
0.822
Gnomad NFE
AF:
0.691
Gnomad OTH
AF:
0.747
GnomAD4 exome
AF:
0.714
AC:
147
AN:
206
Hom.:
53
Cov.:
0
AF XY:
0.743
AC XY:
110
AN XY:
148
show subpopulations
African (AFR)
AF:
0.625
AC:
5
AN:
8
American (AMR)
AF:
1.00
AC:
2
AN:
2
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
0.750
AC:
3
AN:
4
South Asian (SAS)
AF:
0.833
AC:
5
AN:
6
European-Finnish (FIN)
AF:
0.750
AC:
15
AN:
20
Middle Eastern (MID)
AF:
1.00
AC:
2
AN:
2
European-Non Finnish (NFE)
AF:
0.697
AC:
106
AN:
152
Other (OTH)
AF:
0.750
AC:
9
AN:
12
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
3
6
8
11
14
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.752
AC:
114341
AN:
152104
Hom.:
43305
Cov.:
33
AF XY:
0.755
AC XY:
56137
AN XY:
74338
show subpopulations
African (AFR)
AF:
0.833
AC:
34589
AN:
41506
American (AMR)
AF:
0.765
AC:
11695
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.817
AC:
2834
AN:
3468
East Asian (EAS)
AF:
0.797
AC:
4100
AN:
5142
South Asian (SAS)
AF:
0.802
AC:
3864
AN:
4818
European-Finnish (FIN)
AF:
0.738
AC:
7795
AN:
10568
Middle Eastern (MID)
AF:
0.832
AC:
243
AN:
292
European-Non Finnish (NFE)
AF:
0.691
AC:
47012
AN:
67996
Other (OTH)
AF:
0.743
AC:
1570
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
1452
2904
4357
5809
7261
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
850
1700
2550
3400
4250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.693
Hom.:
18190
Bravo
AF:
0.757
Asia WGS
AF:
0.789
AC:
2745
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

May 08, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 11940086)

Familial High Density Lipoprotein Deficiency Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Tangier disease Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
14
DANN
Benign
0.62
PhyloP100
-0.43
PromoterAI
0.0042
Neutral

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2740483; hg19: chr9-107690535; API